Results 141 to 150 of about 87,091 (254)
Aminoquinoline antimalarial drugs and drug candidates.
Aminoquinoline antimalarial drugs and drug candidates.
Christiane Deregnaucourt (815024) +7 more
core +1 more source
ABSTRACT Severe Plasmodium vivax malaria may cause vasopressor‐requiring shock, profound thrombocytopenia, jaundice, coagulation activation, and transient cardiopulmonary abnormalities. Early parasite confirmation and close monitoring for evolving organ dysfunction are essential.
Bushra Majid +8 more
wiley +1 more source
Hydroxychloroquine‐Associated Renal Phospholipidosis: A Forgotten Complication of a Common Drug
ABSTRACT Hydroxychloroquine (HCQ) treatment in systemic lupus erythematosus can induce drug‐induced phospholipidosis mimicking Fabry disease. A 32‐year‐old woman with lupus nephritis developed podocyte “zebra bodies” on electron microscopy. Normal lyso‐Gb3 excluded Fabry disease, confirming HCQ toxicity.
Yu‐Chien Tsao, Chun‐Hsin Wu
wiley +1 more source
Se realizó una evaluación in vivo de la actividad antimalárica de las hojas, flores, frutos, corteza y raíz de 25 plantas de la Reserva Biológica Alberto Manuel Brenes (REBAMB), situada en San Ramón, Alajuela, Costa Rica.
MISAEL CHINCHILLA-CARMONA +7 more
doaj
Repurposing Drugs for Malaria through a Human Dose Prediction: A Case Study with Berzosertib
Repurposing drugs whose clinical safety has been established offers a valuable approach to reduce the cost and time associated with the development of new drugs for malaria. Here, we investigate the potential to repurpose the anticancer kinase inhibitor berzosertib for the treatment of malaria, by assessing whether a predicted efficacious human dose ...
Devasha Redhi +5 more
wiley +1 more source
From Prediction to Decision Making: PBPK and QSP as Regulatory‐Grade NAMs
New approach methodologies (NAMs) encompass a diverse and rapidly evolving set of experimental and computational tools designed to generate human‐relevant mechanistic data for use in drug development and regulatory decision making. Experimental NAMs provide insights into drug disposition, pharmacological activity, and disease biology that are difficult
Karen Rowland Yeo, Piet H. van der Graaf
wiley +1 more source
Background: Therapeutic efcacy studies in uncomplicated Plasmodium falciparum malaria are confounded by new infections, which constitute competing risk events since they can potentially preclude/pre-empt the detection of subsequent recrudescence of ...
Bassat Orellana, Quique +1 more
core
The study investigated the phytochemical composition of Vachellia tortilis subsp. raddiana leaf and gum extracts using HPLC‐DAD‐ESI‐MS/MS and evaluated their antioxidant and antidiabetic activities. The leaf extract showed a higher content of phenolic and flavonoid compounds and exhibited promising antioxidant and α‐amylase inhibitory activities ...
Douae Taha +7 more
wiley +1 more source
Hydroxamic Acids as HDAC Inhibitor Drug Leads for Malaria
ABSTRACT Malaria is a global health threat, with an estimated 282 million cases and 610,000 malaria‐associated deaths reported in 2024. Most mortality is due to infection by Plasmodium falciparum parasites, with the highest burden occurring in Sub‐Saharan Africa.
Wisam A. Dawood +7 more
wiley +1 more source

